David Creely

927 total citations
10 papers, 731 citations indexed

About

David Creely is a scholar working on Pharmacology, Molecular Medicine and Pollution. According to data from OpenAlex, David Creely has authored 10 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 4 papers in Molecular Medicine and 3 papers in Pollution. Recurrent topics in David Creely's work include Antibiotic Resistance in Bacteria (4 papers), Pharmaceutical and Antibiotic Environmental Impacts (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). David Creely is often cited by papers focused on Antibiotic Resistance in Bacteria (4 papers), Pharmaceutical and Antibiotic Environmental Impacts (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). David Creely collaborates with scholars based in United States, France and Bangladesh. David Creely's co-authors include Peter C. Isakson, Scott D. Hauser, James K. Gierse, Carol M. Koboldt, Shaukat H. Rangwala, Karen Seibert, Gwen G. Krivi, Karl J. Mathis, D. Welsch and Dee Shortridge and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemical Journal.

In The Last Decade

David Creely

10 papers receiving 693 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Creely United States 8 318 228 138 125 92 10 731
Ryuta Yamazaki Japan 18 280 0.9× 543 2.4× 120 0.9× 103 0.8× 14 0.2× 33 1.1k
Yun‐Jeong Jeong South Korea 22 399 1.3× 584 2.6× 88 0.6× 139 1.1× 43 0.5× 59 1.3k
B Duranton France 14 104 0.3× 591 2.6× 59 0.4× 41 0.3× 25 0.3× 22 1.1k
Lian‐Qiu Wu China 16 168 0.5× 347 1.5× 87 0.6× 97 0.8× 8 0.1× 49 895
Melanie R. Power Coombs Canada 17 98 0.3× 382 1.7× 35 0.3× 202 1.6× 39 0.4× 28 859
Eman El‐Ahwany Egypt 23 68 0.2× 662 2.9× 68 0.5× 120 1.0× 78 0.8× 57 1.3k
Michael Wong United States 13 44 0.1× 226 1.0× 73 0.5× 60 0.5× 77 0.8× 22 549
Helen Chan Hong Kong 15 180 0.6× 336 1.5× 96 0.7× 79 0.6× 15 0.2× 25 816
Attilio Crea Germany 18 157 0.5× 263 1.2× 24 0.2× 237 1.9× 13 0.1× 55 1.0k
Martin Raabe United States 13 57 0.2× 547 2.4× 79 0.6× 65 0.5× 20 0.2× 13 1.1k

Countries citing papers authored by David Creely

Since Specialization
Citations

This map shows the geographic impact of David Creely's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Creely with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Creely more than expected).

Fields of papers citing papers by David Creely

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Creely. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Creely. The network helps show where David Creely may publish in the future.

Co-authorship network of co-authors of David Creely

This figure shows the co-authorship network connecting the top 25 collaborators of David Creely. A scholar is included among the top collaborators of David Creely based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Creely. David Creely is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Schechter, Lisa M., David Creely, Cherilyn D. Garner, et al.. (2018). Extensive Gene Amplification as a Mechanism for Piperacillin-Tazobactam Resistance in Escherichia coli. mBio. 9(2). 55 indexed citations
2.
Jaillard, Magali, Alex van Belkum, Kyle C. Cady, et al.. (2017). Correlation between phenotypic antibiotic susceptibility and the resistome in Pseudomonas aeruginosa. International Journal of Antimicrobial Agents. 50(2). 210–218. 45 indexed citations
3.
Rychert, Jenna, David Creely, Leslie M. Mayo-Smith, et al.. (2014). Evaluation of Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry for Identification of Vibrio cholerae. Journal of Clinical Microbiology. 53(1). 329–331. 10 indexed citations
4.
Creely, David, et al.. (2013). International dissemination of Escherichia coli strains with discrepant behaviour in phenotypic antimicrobial susceptibility tests. European Journal of Clinical Microbiology & Infectious Diseases. 32(8). 997–1002. 7 indexed citations
5.
Creely, David, et al.. (2013). Population Analysis of Escherichia coli Isolates with Discordant Resistance Levels by Piperacillin-Tazobactam Broth Microdilution and Agar Dilution Testing. Antimicrobial Agents and Chemotherapy. 58(3). 1779–1781. 15 indexed citations
6.
Griffith, R. S., David Creely, Paula A. Revell, William M. Dunne, & Dee Shortridge. (2009). Comparison of Three Reference Methods for Testing Susceptibility of Staphylococci to Trimethoprim-Sulfamethoxazole. Journal of Clinical Microbiology. 47(11). 3726–3728. 4 indexed citations
7.
Kishore, Nandini, Q K Huynh, Sumathy Mathialagan, et al.. (2002). IKK-i and TBK-1 are Enzymatically Distinct from the Homologous Enzyme IKK-2. Journal of Biological Chemistry. 277(16). 13840–13847. 115 indexed citations
8.
9.
Gierse, James K., Scott D. Hauser, David Creely, et al.. (1995). Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase. Biochemical Journal. 305(2). 479–484. 350 indexed citations
10.
Welsch, D., David Creely, Scott D. Hauser, et al.. (1994). Molecular cloning and expression of human leukotriene-C4 synthase.. Proceedings of the National Academy of Sciences. 91(21). 9745–9749. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryuta Yamazaki Breakdown of academic impact, for papers by Yun‐Jeong Jeong Breakdown of academic impact, for papers by B Duranton Breakdown of academic impact, for papers by Lian‐Qiu Wu Breakdown of academic impact, for papers by Melanie R. Power Coombs Breakdown of academic impact, for papers by Eman El‐Ahwany Breakdown of academic impact, for papers by Michael Wong Breakdown of academic impact, for papers by Helen Chan Breakdown of academic impact, for papers by Attilio Crea Breakdown of academic impact, for papers by Martin Raabe
Rankless by CCL
2026